Literature DB >> 12073004

Complications and feasibility of laparoscopic adhesiolysis in patients with chronic abdominal pain. A retrospective study.

D J Swank1, W F M van Erp, O J Repelaer van Driel, W C J Hop, H J Bonjer, J Jeekel.   

Abstract

BACKGROUND: A retrospective study was done to determine whether laparoscopic adhesiolysis benefits patients with chronic abdominal pain. Factors that influence complications and feasibility of laparoscopic adhesiolysis were evaluated.
METHODS: 174 consecutive operations in 157 patients were retrospectively analyzed for factors which might influence the complication rate and the feasibility of laparoscopic adhesiolysis.
RESULTS: In 128 out of 174 procedures a complete adhesiolysis was performed. We had to accept an incomplete adhesiolysis in 39 other patients and in 7 patients a primary conversion was needed. We noticed 16 major complications. Two patients died. Relief of pain was recorded in 80% of patients after short follow-up. The number of previous abdominal operations and patient age significantly affected the outcome of surgery.
CONCLUSION: Laparoscopic adhesiolysis in patients with chronic abdominal pain seems to be a feasible and effective operation with considerable risk.

Entities:  

Mesh:

Year:  2002        PMID: 12073004     DOI: 10.1007/s00464-002-0008-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  3 in total

1.  Caeco-peritoneal band as a potential cause of right iliac fossa pain in children.

Authors:  R S Wong; R Lahiri; Anies Mahomed
Journal:  Pediatr Surg Int       Date:  2014-11-04       Impact factor: 1.827

2.  Inadvertent enterotomy in minimally invasive abdominal surgery.

Authors:  Steven J Binenbaum; Michael A Goldfarb
Journal:  JSLS       Date:  2006 Jul-Sep       Impact factor: 2.172

3.  Two Cases of Laparoscopic Adhesiolysis for Chronic Abdominal Pain without Intestinal Obstruction after Total Gastrectomy.

Authors:  Hyun Jung Choi; Sang Chul Yoon; Yong Jin Kim
Journal:  J Gastric Cancer       Date:  2012-12-31       Impact factor: 3.720

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.